MarketWatch (press release) The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent expirations of the key blockbuster revenue generating drugs such as Cymbalta ( duloxetine ) of Eli Lilly & Co. and ... and more »
PharmaTimes Major-market sales in the unipolar depression market are set to decline 30% during 2012-22 because of the entry of generic versions of the current blockbusters escitalopram, aripiprazole and duloxetine , as well as expanded generic competition for ...
PMLiVE AMRI said that BMS took the decision because BMS-820836 had failed to show it was any better than Lilly's serotonin and norepinephrine reuptake inhibitor (SNRI) C...
PMLiVE Approval would provide a welcome boost for Lilly, which is weathering the loss of marketing exclusivity for a number of top-selling drugs, including the antidepressant Cymbalta ( duloxetine ). Meanwhile it has suffered a string of setbacks in its ... and more »
PharmaTimes Now, Lilly is facing the start of generic competition to $5 billion-a-year antidepressant Cymbalta ( duloxetine ) in the US from December this year, while $1bn breast cancer drug Evista (raloxifene) loses patent protection in 2014. A US district court ... and more »
Medical Daily BMS-820836 showed no benefit over duloxetine (Cymbalta), an SNRI, or escitalopram (Lexapro), an SSRI, in patients with TRD during two phase IIb clinical ...
San Francisco Chronicle (press release) The loss of patent exclusivity of other key brands such as Cymbalta ( duloxetine ), OxyContin (oxycodone) and Lidoderm (lidocaine) scheduled in the year 2013 will have a profound impact on the growth of the overall market. North America was the largest ... and more »
Onlymyhealth Medications such as anticholinergics, topical estrogen, imipramine and duloxetine are most commonly used to treat incontinence. These are usually used in conjunction with behavioural techniques. [Read: How to Deal with Stress Urinary Incontinence].
Times of India Some antidepressants (like amitriptyline, imipramine and duloxetine ) can be given to diabetics to give them relief from pain. However, their prolonged use can have side effects like constipation, drowsiness and headaches. Nerve supplements such as ...
